Clinical Trials · NCT01950403

Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers

Name: Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Linaclotide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Mayo Clinic
Enrollment: 24
Start date: Sep 2013
Locations: 1 site, United States
Primary endpoint: Dose of linaclotide acetate that produces a 60% response rate for cGMP levels in rectal tissue by radioimmunoassay (RIA)

View Linaclotide compound reference